Warburg Pincus

Warburg Pincus related stories

All articles and analysis

• 
  Rib-X Pharma Raises $25 Million

  VCJ Staff- 4 February 2009

  Rib-X Pharmaceuticals Inc., a New Haven, Conn.-based developer of antibiotics for the treatment of antibiotic-resistant infections, has raised $25 million in fourth-round funding. Return backers include Warburg Pincus, ABS Ventures, Axiom Ventures, EuclidSR Partners, MedImmune Ventures, Oxford Bioscience Partners, S.R. One and Vox Equity Partners I. The company had previously raised over $120 million.

• 
  Exit watch, week of Feb. 2, 2009

  Brad Meikle- 2 February 2009

  News briefs about Centive, Groople, Brabeion and other VC-backed companies that were bought in the past week

• 
  Exits

  Brad Meikle- 2 February 2009
• 
  Fundraising of the Year – Venture

  Brad Meikle- 1 February 2009

  Index Ventures

• 
  Q4 fund-raising, deal making tumble

  Staff Writer- 1 February 2009

  It was a tough fourth quarter, with a 71% drop in fund-raising and a reported 30% decline in deal making

• 
  Deal making tumbles as economy slides

  Brad Meikle- 26 January 2009

  DFJ, KP, Sequoia and others cut pace in Q4

• 
  Kleiner Perkins, Sequoia Slow It Down

  Connie Loizos- 23 January 2009
• 
  Swedish Space Buying Universal Space Network

  VCJ Staff- 22 January 2009
• 
  Funds Eye GOME Stake

  PE Hub Staff- 22 January 2009
• 
  PE Week Wire: Thursday, January 22, 2009

  Brad Meikle- 22 January 2009

  Random Ramblings